Targeting of Drugs 6 (eBook, PDF)
Strategies for Stealth Therapeutic Systems
Redaktion: Gregoriadis, Gregory; McCormack, Brenda
113,95 €
113,95 €
inkl. MwSt.
Sofort per Download lieferbar
57 °P sammeln
113,95 €
Als Download kaufen
113,95 €
inkl. MwSt.
Sofort per Download lieferbar
57 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
113,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
57 °P sammeln
Targeting of Drugs 6 (eBook, PDF)
Strategies for Stealth Therapeutic Systems
Redaktion: Gregoriadis, Gregory; McCormack, Brenda
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Proceedings of a NATO ASI held in Cape Sounion Beach, Greece, June 24-July 5, 1997
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 35.64MB
Proceedings of a NATO ASI held in Cape Sounion Beach, Greece, June 24-July 5, 1997
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer US
- Seitenzahl: 302
- Erscheinungstermin: 29. Juni 2013
- Englisch
- ISBN-13: 9781489901279
- Artikelnr.: 44172983
- Verlag: Springer US
- Seitenzahl: 302
- Erscheinungstermin: 29. Juni 2013
- Englisch
- ISBN-13: 9781489901279
- Artikelnr.: 44172983
Interactions between Blood Components and Artificial Surfaces.- The Mononuclear Phagocyte System: Features Relevant to Interactions with Liposomes.- Stealth(TM) Therapeutic Systems: Rationale and Strategies.- Long Circulating Liposomes: Evolution of the Concept.- Sterically Stabilized Immunoliposomes: Formulations for Delivery of Drugs and Genes to Tumor Cells in Vivo..- Pegylation of Liposomes in Cell-Specific Targeting: It Does Not Always Make Sense.- Stealth(TM) Liposomes for the Targeting of Drugs in Cancer Therapy.- Stealth(TM) Liposomes as Carriers of Doxorubicin.- Liposome-Mediated Delivery of Retinoids.- Applications of Liposome Technology to Overcome Multidrug Resistance in Solid Tumors.- Use of Radiolabeled Liposomes for PEG-Liposome-Based Drug Targeting and Diagnostic Imaging Applications.- Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes.- Biologically Active Ligand-Bearing Polymer-Grafted Liposomes.- Engineering Stealth(TM) Liposome Surfaces: Exercises in Colloid Chemistry Principles.- The Role of Hydration in Stabilization of Liposomes: Resistance to Oxidative Damage of PEG-Grafted Liposomes.- Physicochemical Characterization of DOTAP-Containing Lipoplexes by Fluorescent Probes: Relevance to Lipofection.- Steric Stabilization of Cationic Liposome-DNA Complexes: Influence on Morphology and Transfection Activity.- Polysialic Acids: Potential for Long Circulating Drug, Protein, Liposome and Other Microparticle Constructs.- Tailor-Made Soluble Polymer Carriers.- Development of Novel Technologies for the Synthesis of Biodegradable Pegylated Nanoparticles.- Development of a New Class of Nanoparticles which Avoid Phagocytosis by Inhibiting Complement Activation.- Coating of Nanoparticles withSurfactants: Targeting versus Prolonged Circulation.- Recent Developments and Limitations of Poloxamine-Coated Long-Circulating Particles in Experimental Drug Delivery.- PEG-Coated Nanospheres: Surface Optimization and Therapeutic Applications.- Participants' Photograph.- Contributors.
Interactions between Blood Components and Artificial Surfaces.- The Mononuclear Phagocyte System: Features Relevant to Interactions with Liposomes.- Stealth(TM) Therapeutic Systems: Rationale and Strategies.- Long Circulating Liposomes: Evolution of the Concept.- Sterically Stabilized Immunoliposomes: Formulations for Delivery of Drugs and Genes to Tumor Cells in Vivo..- Pegylation of Liposomes in Cell-Specific Targeting: It Does Not Always Make Sense.- Stealth(TM) Liposomes for the Targeting of Drugs in Cancer Therapy.- Stealth(TM) Liposomes as Carriers of Doxorubicin.- Liposome-Mediated Delivery of Retinoids.- Applications of Liposome Technology to Overcome Multidrug Resistance in Solid Tumors.- Use of Radiolabeled Liposomes for PEG-Liposome-Based Drug Targeting and Diagnostic Imaging Applications.- Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes.- Biologically Active Ligand-Bearing Polymer-Grafted Liposomes.- Engineering Stealth(TM) Liposome Surfaces: Exercises in Colloid Chemistry Principles.- The Role of Hydration in Stabilization of Liposomes: Resistance to Oxidative Damage of PEG-Grafted Liposomes.- Physicochemical Characterization of DOTAP-Containing Lipoplexes by Fluorescent Probes: Relevance to Lipofection.- Steric Stabilization of Cationic Liposome-DNA Complexes: Influence on Morphology and Transfection Activity.- Polysialic Acids: Potential for Long Circulating Drug, Protein, Liposome and Other Microparticle Constructs.- Tailor-Made Soluble Polymer Carriers.- Development of Novel Technologies for the Synthesis of Biodegradable Pegylated Nanoparticles.- Development of a New Class of Nanoparticles which Avoid Phagocytosis by Inhibiting Complement Activation.- Coating of Nanoparticles withSurfactants: Targeting versus Prolonged Circulation.- Recent Developments and Limitations of Poloxamine-Coated Long-Circulating Particles in Experimental Drug Delivery.- PEG-Coated Nanospheres: Surface Optimization and Therapeutic Applications.- Participants' Photograph.- Contributors.